A rare stem cell in the blood, a progenitor, functions as a barometer for macular degeneration activity. The UNC test is able to measure the progress of the disease through the progenitor.
The UNC small pilot test will move forward to a multicenter trial.
More Articles on Ophthalmology:
10 Eye Specialists Earn National Awards for One-Page Proposals
C-Reactive Protein Again Linked to Macular Degeneration
Houston Ophthalmologists Named ‘Best Doctors’
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
